Market Overview - Despite a decrease in newborn numbers, the pediatric medicine industry continues to grow rapidly, driven by a large market size of approximately 250 million children aged 0-14 in China [2][3] - The Chinese pediatric medicine market faces challenges such as limited varieties and specifications, which are accelerating industry development and increasing the introduction of new products [3][4] - Government policies are increasingly supportive of pediatric medicines, with recent adjustments to the medical insurance catalog favoring traditional Chinese medicine and pediatric drugs, indicating a growth phase for this market [3][4] Sales and Distribution Models - The company's main business model is divided into three segments: direct sales, distribution, and traditional agency models [3][4] - The direct sales model connects the company directly with retail pharmacies, allowing for better market feedback and sales strategy adjustments [3][4] - The distribution model focuses on delivering products to hospitals and clinics, enhancing cooperation with medical institutions and increasing brand visibility [3][4] - The traditional agency model leverages distributors to achieve broad market coverage, catering to diverse regional and customer needs [3][4] Product Management and Strategy - The company has over 100 products on the market, with plans to launch more new products in the next 1 to 3 years, enriching its product structure [5][6] - Core products like "Pediatric Lung Heat Cough Granules" account for approximately 60% of sales in the hospital market, while also achieving nationwide coverage in the OTC market [6][7] - Future growth drivers include expanding product lines from acquired assets and developing new products with strong market potential [6][7] Market Trends and Consumer Behavior - There is a noticeable shift in consumer behavior, with parents increasingly opting for hospital visits for pediatric treatment rather than self-medication [5][6] - The pediatric medicine market is showing steady growth, particularly in the hospital sector, driven by rising demand for precision and professionalism in pediatric treatments [5][6] - The company aims to enhance product development, service quality, and brand building to solidify its position in the pediatric medicine market [5][6]
葫芦娃(605199) - 海南葫芦娃药业集团股份有限公司投资者关系活动记录表